KeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55 and Maintains an Overweight Rating

Hinge Health, Inc. (NYSE:HNGE) is among the 11 Newly-Listed NYSE Stocks to Buy Now. KeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55 and Maintains an Overweight Rating On February 11, 2026, KeyBanc reduced its price target on Hinge Health, Inc. (NYSE:HNGE) to $55 from $70 and maintained an Overweight rating. That same day, Evercore ISI analyst Elizabeth Anderson lowered the price target to $50 from $65 while keeping an Outperform rating. Elizabeth Anderson said Hinge Health exceeded ...